PUTNAM INVESTMENTS LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,206,696
+17.9%
267,191
+11.3%
0.02%
+23.1%
Q2 2023$8,657,052
-20.6%
240,007
-16.0%
0.01%
-23.5%
Q1 2023$10,909,470
-38.1%
285,663
-7.8%
0.02%
-45.2%
Q4 2022$17,627,621
+43.6%
309,800
-0.2%
0.03%
+34.8%
Q3 2022$12,275,000
-11.0%
310,429
-0.9%
0.02%
-8.0%
Q2 2022$13,785,000
+11.1%
313,296
+0.7%
0.02%
+31.6%
Q1 2022$12,406,000
-3.6%
311,089
-2.8%
0.02%
+5.6%
Q4 2021$12,866,000
+2.2%
319,969
+3.4%
0.02%
-10.0%
Q3 2021$12,593,000
-2.9%
309,555
+8.4%
0.02%0.0%
Q2 2021$12,971,000
+8.9%
285,6390.0%0.02%0.0%
Q1 2021$11,908,000
+76.9%
285,639
+81.2%
0.02%
+66.7%
Q4 2020$6,732,000
+682.8%
157,623
+137.5%
0.01%
+500.0%
Q1 2017$860,000
+16.8%
66,359
-10.9%
0.00%0.0%
Q4 2016$736,000
-20.4%
74,509
-2.7%
0.00%0.0%
Q3 2016$925,000
-15.8%
76,602
-39.8%
0.00%
-33.3%
Q2 2016$1,099,000
+37.2%
127,328
+50.6%
0.00%
+50.0%
Q1 2016$801,000
-44.2%
84,540
+2.1%
0.00%
-33.3%
Q4 2015$1,435,000
+102.1%
82,784
+56.6%
0.00%
+50.0%
Q3 2015$710,00052,8520.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders